We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
-1.44%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$244M
AUM Growth
-$55.3M
Cap. Flow
-$44.9M
Cap. Flow %
-18.39%
Top 10 Hldgs %
47.87%
Holding
229
New
82
Increased
25
Reduced
61
Closed
60

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.17M
2
PM icon
Philip Morris
PM
+$1.84M
3
CL icon
Colgate-Palmolive
CL
+$1.83M
4
RTX icon
RTX Corp
RTX
+$1.82M
5
PG icon
Procter & Gamble
PG
+$1.81M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.5M
2
KO icon
Coca-Cola
KO
+$1.81M
3
MRK icon
Merck
MRK
+$1.72M
4
ACN icon
Accenture
ACN
+$1.23M
5
XOM icon
ExxonMobil
XOM
+$1.22M

Sector Composition

Rank Sector Weight
1 Technology 13.37%
2 Healthcare 12.44%
3 Financials 8.73%
4 Consumer Staples 6.45%
5 Industrials 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
76
NVIDIA
NVDA
$5.42T
$741K 0.3%
17,030
-8,240
-33% -$369K
EXP icon
77
Eagle Materials
EXP
$6.38B
$685K 0.28%
4,115
-1,567
-28% -$285K
BLD
78
DELISTED
TopBuild
BLD
$677K 0.28%
2,691
+1,866
+226% +$514K
NOW icon
79
ServiceNow
NOW
$128B
$653K 0.27%
+5,845
New +$667K
GH icon
80
Guardant Health
GH
$22.2B
$639K 0.26%
+21,566
New +$758K
MRTX
81
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$628K 0.26%
+14,423
New +$515K
MRNS
82
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$621K 0.25%
+77,083
New +$641K
HUBS icon
83
HubSpot
HUBS
$10.5B
$608K 0.25%
1,234
-177
-13% -$92.5K
SENT
84
DELISTED
AdvisorShares Alpha DNA Equity Sentiment ETF
SENT
$608K 0.25%
27,323
+9,213
+51% +$217K
OKTA icon
85
Okta
OKTA
$26.3B
$601K 0.25%
7,378
-3,485
-32% -$264K
MRUS
86
DELISTED
Merus
MRUS
$598K 0.24%
25,380
-3,437
-12% -$83.4K
WIX icon
87
WIX.com
WIX
$2.77B
$593K 0.24%
6,461
-3,566
-36% -$319K
DVAX
88
DELISTED
Dynavax Technologies
DVAX
$593K 0.24%
+40,134
New +$564K
MNDY icon
89
monday.com
MNDY
$3.58B
$588K 0.24%
3,696
-1,299
-26% -$218K
CNX icon
90
CNX Resources
CNX
$5.28B
$587K 0.24%
+26,003
New +$539K
TNK icon
91
Teekay Tankers
TNK
$2.76B
$584K 0.24%
+14,030
New +$573K
SM icon
92
SM Energy
SM
$7.74B
$584K 0.24%
+14,723
New +$558K
RXST icon
93
RxSight
RXST
$289M
$582K 0.24%
+20,879
New +$623K
TRUP icon
94
Trupanion
TRUP
$1.32B
$581K 0.24%
+20,595
New +$585K
VTLE
95
DELISTED
Vital Energy
VTLE
$579K 0.24%
+10,453
New +$561K
EXAS
96
DELISTED
Exact Sciences
EXAS
$576K 0.24%
8,449
-3,221
-28% -$273K
BRZE icon
97
Braze
BRZE
$3.11B
$576K 0.24%
+12,324
New +$542K
OSW icon
98
OneSpaWorld
OSW
$2.67B
$574K 0.23%
51,159
-21,670
-30% -$253K
LYFT icon
99
Lyft
LYFT
$6.31B
$574K 0.23%
+54,437
New +$607K
SUM
100
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$574K 0.23%
+18,423
New +$656K
2 3
4
5 6

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Alpha DNA Investment Management held 229 positions worth $244M, down 18% from $300M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Alpha DNA Investment Management withdrew a net $44.9M in Q3 2023, closing 60 positions and reducing 61 holdings. Its most notable exit was Parker-Hannifin, an estimated $1.21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Alpha DNA Investment Management opened a new position in Becton Dickinson worth $2.07M.

  • Alpha DNA Investment Management's largest Q3 2023 buy was Becton Dickinson: 8,016 shares worth $2.07M.
  • Alpha DNA Investment Management added most to Microsoft in Q3 2023, an estimated $1.03M increase.
  • Alpha DNA Investment Management's biggest Q3 2023 reduction was Visa, cutting an estimated $2.5M.
  • Alpha DNA Investment Management fully exited Parker-Hannifin in Q3 2023, selling an estimated $1.21M.
  • Alpha DNA Investment Management's ten largest holdings make up 48% of its $244M portfolio in Q3 2023.
  • Alpha DNA Investment Management opened 82 new positions and closed 60 in Q3 2023.
  • Alpha DNA Investment Management's portfolio value fell 18% quarter-over-quarter to $244M.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.